Variant report
Variant | nsv518845 |
---|---|
Chromosome Location | chr5:58675538-58676049 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10514865 | chr5:58675538-58675539 | Weak transcription Enhancers Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs244588 | chr5:58675557-58675558 | Weak transcription Enhancers Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs543909436 | chr5:58675558-58675559 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs574373413 | chr5:58675561-58675562 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs564190903 | chr5:58675579-58675580 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs532910621 | chr5:58675639-58675640 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs57695545 | chr5:58675721-58675722 | Weak transcription Enhancers Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs441683 | chr5:58675764-58675765 | Weak transcription Enhancers Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs387997 | chr5:58675767-58675768 | Weak transcription Enhancers Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs116088103 | chr5:58675789-58675790 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs182686767 | chr5:58675836-58675837 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs186629832 | chr5:58675882-58675883 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs60958690 | chr5:58675911-58675912 | Weak transcription Enhancers Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs1823066 | chr5:58675953-58675954 | Weak transcription Enhancers Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs80156618 | chr5:58675997-58675998 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs1823067 | chr5:58676021-58676022 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs191579166 | chr5:58676045-58676046 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
18 | rs1823068 | chr5:58676049-58676050 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | disease |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 21911935 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Lung adenocarcinoma | 17982442 | CNVD |
Breast cancer | 21364760 | CNVD |
Melanoma | 17363583 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Schizophrenia | 20967226 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:58666000-58681400 | Weak transcription | Psoas Muscle | Psoas |
2 | chr5:58668000-58676200 | Weak transcription | Fetal Intestine Small | intestine |
3 | chr5:58668800-58675600 | Weak transcription | Pancreas | Pancrea |
4 | chr5:58671000-58676200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr5:58672200-58689200 | Weak transcription | Fetal Brain Female | brain |
6 | chr5:58672800-58681600 | Weak transcription | Placenta Amnion | Placenta Amnion |
7 | chr5:58673800-58677400 | Weak transcription | Fetal Intestine Large | intestine |
8 | chr5:58674400-58676000 | Genic enhancers | A549 | lung |
9 | chr5:58674800-58676800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
10 | chr5:58675000-58676200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr5:58675000-58677400 | Weak transcription | Fetal Brain Male | brain |
12 | chr5:58675400-58681400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
13 | chr5:58675800-58676800 | Enhancers | Hela-S3 | cervix |
14 | chr5:58676000-58676200 | Enhancers | A549 | lung |
15 | chr5:58676000-58676400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
16 | chr5:58676000-58676400 | Bivalent Enhancer | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |